PHARMACEUTICAL CLEANING: A RESEARCH AND METHODOLY APPROACH Adeyinka Aina 1#, Chris Edlin 1 and Charles Gordon 2 1. Pharmaceutical Manufacturing and Technology.

Slides:



Advertisements
Similar presentations
Ian Robertson Chief Executive Developing Entrepreneurship as a Corporate Growth Strategy Developing People for Growth and Innovation Sri Lanka 5 th March.
Advertisements

Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:
The EHPM Quality Guide: A template for best practice 10 December 2014 Michel Horn EHPM Quality Working Group.
Test Automation Success: Choosing the Right People & Process
Why does PAT need Rapid Microbiology Methods? S.Lonardi, P.J.Newby, D.Ribeiro, B.Johnson PAT Subcommittee meeting October 23, 2002.
Supporting Business to Address Skills Issues. Background Economic powerhouse Diversify the economy by facilitating the development of emerging industries.
Global Context As the rich world gets older and sicker and the poor world gets wealthier and fatter, the demand for medical innovation is exploding. Clever.
Successor to the Strategy for Science, Technology and Innovation HRB and Department of Health Consultation Workshop 11 March 2015 Dermot Curran Assistant.
End of Waste – Experiences from the UK Roger Hoare, Environment Agency 3rd October 2013 Malta 2013 IMPEL Conference on Implementation and Enforcement of.
Validation Part 2: Cleaning validation
Viewpoint Consulting – Committed to your success.
22 Feb 2007EU-Russia Co-operation1 Dr. Stephan Pascall Advisor to the Director Directorate G: Components and Systems DG Information Society and Media European.
Robust and affordable process control technologies for improving standards and optimising industrial operations Pau Puigdollers Project Coordinator.
Regional and local economics Slide 1 Lecture 9b The Renaissance of local economic regeneration in the UK – Main themes and activities Aims  Examine local.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
Rodney Mullins, Manufacturing Consultant InSource Software Solutions Business Center Drive Richmond, VA (804) MES “Unlocking The Value.
The Global Procurement Network NSW Social and Sustainable Procurement Forum ‘Modern Strategic Procurement Practice and the integration of the Quadruple.
Sector Specific Investment Promotion - Ireland Barry O’Leary CEO, IDA Ireland May 3 rd 2013.
Demand Policy for Innovation The Australian Experience
1 European Conference on Training Strategies Kieran Cox -NSAI Education & Promotion-
1 Module 4: Designing Performance Indicators for Environmental Compliance and Enforcement Programs.
Alabama Institute for Manufacturing Excellence INNOVATIVE TECHNOLOGY AND RESEARCH AT WORK.
Partnerships and collaboration Working together: good for business, good for research I work for business.gov.au but also thought it would be a good opportunity.
Compliance in the Supply Chain – Implications of SOX on UK Businesses Dr. Jean-Anne Stewart.
Business Model for an Industrial development agency
INTOSAI Public Debt Working Group Updating of the Strategic Plan Richard Domingue Office of the Auditor General of Canada June 14, 2010.
Kathleen Donahue Damodar Rao Gummadapu Aspiring High. Above and Beyond, Our Journey to “Be the Best” Business Process Intelligence.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
Information Security Research and Education Network INSuRE Dr. Melissa Dark Purdue University Award #
1 Introduction of Research and Development Project Evaluation System at NEDO Momoko OKADA New Energy and Industrial Technology Development Organization(NEDO)
“Enterprise Ireland – Driving Innovation and Competitiveness in Irish Business” 6 th May 2011 Frank Ryan CEO Enterprise Ireland BMW Assembly 2011 Annual.
Knowledge Transfer Programme: An Overview Marc Fleetham Director Business Solutions.
The HMO Research Network (HMORN) is a well established alliance of 18 research departments in the United States and Israel. Since 1994, the HMORN has conducted.
Risk-Based CMC Review - OGD Perspective Gary J. Buehler, R.Ph. Director Office of Generic Drugs July 21, 2004 Advisory Committee for Pharmaceutical Science.
Molecule-to-Market-Place Quality
Sport and Recreation Spatial Background and demonstration.
Quality Assuring Deliverers of Education and Training for the Nuclear Sector Jo Tipa Operations Director National Skills Academy for Nuclear.
Australian Injury & Disability Insurance Network AIIN Health Special Interest Group & ICT Geelong November
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
Enterprise & Environment Directorate TRANSPORT FOR REGIONAL GROWTH 5 NOVEMBER 2015 Keith Winter, Executive Director, Enterprise and Environment, Fife Council.
CDER / Office of Compliance ACPS October 5, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA.
B IOCHEMICAL T ECHNOLOGY L EADERSHIP R OUNDTABLE (BTLR) Vision: A sustainable chemicals economy Scope: Chemicals made using bio-based and renewable technologies.
ARCH – Applied Research for Connected Health An Enterprise Ireland and IDA Ireland Technology Centre Overview May 2016.
Talent Acquisition, Staffing, Recruitment, Executive Search.
NMBP : Cross-cutting KETs for diagnostics at the point-of-care co-funded by LEIT-NMBP (DG RTD) and LEIT-ICT (DG CONNECT) Opening 20 Sep 2016 Closing.
Impact and the REF Consortium of Institutes of Advanced Study 19 October 2009 David Sweeney Director (Research, Innovation and Skills)
Driving Innovation Technology Strategy Board The UK’s agency for business innovation –Business benefit –Economic growth –Quality of life.
Driving Innovation Competition Scope and Background Merlin Goldman 27 September 2011.
INSERT TITLE HERE.
Contents Playbook Objectives Playbook Value Details Playbook Design
Knowledge Transfer Partnership Project Nottingham Trent University and Nottinghamshire County Council Dr Adam Barnard Rachel Clark Catherine Goodall 19/4/16.
Alberta Livestock and Meat Agency
XS2I4MS – Final Event of the Mentoring and Coaching Programme
SMS Roundtable Discussion NAFEMS Americas 2016, Seattle, WA, USA
Identify the Risk of Not Doing BA
Forging Links with Malaysian Manufacturers
Quality System.
KEYNOTE STAGE SPONSOR.
Bio-Facility Qualification, Start-Up & Licensure
LINX project Total budget: EUR 11 MIO Industry led priorities
Innovative Medicines Initiative:
SwafS Ethics and Research Integrity
Change Assurance Update
GRESB Infrastructure December, 2018.
SwafS Ethics and Research Integrity
MAZARS’ CONSULTING PRACTICE Helping your Business Venture Further
ABCPhD Doctoral Program in architecture, built environment and construction engineering ABCPhD Call4Scholarship 34 RESEARCH TOPIC: Automation, Robotics.
Scaleup Programme Overview & Introduction
PROCESS VALIDATION - ACTUAL REGULATION, PERFORMING AND INSPECTION
Presentation transcript:

PHARMACEUTICAL CLEANING: A RESEARCH AND METHODOLY APPROACH Adeyinka Aina 1#, Chris Edlin 1 and Charles Gordon 2 1. Pharmaceutical Manufacturing and Technology Centre, University of Limerick, Ireland. 2. Britest Limited, The Innovation Centre, Daresbury, Cheshire, WA4 4FS, United Kingdom. Introduction: The Pharmaceutical Manufacturing Technology Centre (PMTC) was established in December 2013 and funded both by Enterprise Ireland and IDA Ireland, supplemented with co-funding from industry and other public sources, its mission is to make Ireland the global hub of pharmaceutical process innovation and advanced manufacturing. It also shares a common vision with other centres by helping to support and develop the Irish pharmaceutical industry (small and large molecule). Companies access PMTC to create projects and execute world-beating industry-relevant research in advanced technology solutions to address contemporary manufacturing issues. In collaboration with leading pharmaceutical companies, PMTC currently has six main themes of research; Cleaning, validation and verification, enabling and control of continuous processing, soft sensor modelling tools, API (Active Pharmaceutical Ingredient) real time release PAT (Process Analytical Technology), powder processing and advanced rapid micro-analytical techniques. In response to developments in the regulatory environment relating to cleaning validation, PMTC commissioned the ‘compliance group’ to deliver a Good Cleaning Validation Practice (GCVP) document. This document was produced based on a review of current guidelines and input from the Health Products Regulatory Agency (HPRA) and industry, it is available online ( Dr. Chris Edlin is the current director of the centre. Vision: To develop the reputation of the PMTC as a world class centre of excellence for pharmaceutical manufacturing issues, with the ability to attract significant future R&D funding from both industrial and EU/National funding agencies. -Collaborative -Inclusive -Shared infrastructure -Connected Ecosystem Project aim: To use an already existing collaboration between Britest, UK and the Pharmaceutical Manufacturing and Technology Centre (PMTC), Ireland, to scope pharmaceutical cleaning research methodologies, using gap analysis, Process Analytical Technology (PAT) and modeling technologies with the aid of proprietary tools (provided by Britest UK). These tools defines, structure and translate process knowledge and information into process understanding. To achieve the above, multiple studies would be carried out at various Irish pharmaceutical companies by both Britest, UK and PMTC. Output from these studies would be made available to participating companies and other generic industry sectors. PMTC will also benefit from these studies in its endeavour to assist local Irish companies improve their competitiveness. Plant cleaning challenges: Low volume High volume cleaning active Drawbacks: - Average cleaning cycle can take up to 15 days Clean-out can require: - 8 tonnes of solvent* -total number of changeovers ~ 53 (2013)* -500 person hours* -~£1mn lost production / cycle* - Decreasing volume requirements result in even greater impact of cleaning on the environment Approach A better understanding of the manufacturing process will help develop a robust cleaning protocol tailored-made for every specific processes. These protocols will then facilitate: - Greener, quicker and cheaper cleaning - Clean General Manufacturing Practice (cGMP) - Help choose appropriate sampling and validation techniques Work plan: Activity Sep/ Oct-15 Nov-15Dec-15Jan-16Jan/ Feb- 16Mar-16Apr-16May-16Jun-16 Training and background Case study 1 Case study 2 Case study 3 Case study analysis Case study 4 Methodology development Case study validation Assessment and future planning Validation: -Visual inspection -Total Organic Carbon (TOC) -Conductivity measurements -High Performance Liquid Chromatography (HPLC) -Ultra Performance Liquid Chromatography (UPLC) -Ultra Violet spectroscopy -Raman spectroscopy Expected outcomes: -Be able to set visual acceptance criteria -Come up versatile approach for detergent removal -Estimate microbiological limits -Merge worst case approach with toxicological limit * Figures presented at the PMTC meeting in May 2015